CXCL12 has chemotactic activity towards cancer and immune cells; in both cell types, it induces cytokines that retain pro-tumour activity and modulate the stromal component [7,16], contributing to a tumour-permissive microenvironment. The gene discussed is CXCL12; the disease is neoplasm.